HSPC152 inhibitors are a class of small molecules that selectively target the HSPC152 protein, which is also known as PGAM5 (phosphoglycerate mutase family member 5). These inhibitors typically interact with the catalytic or regulatory domains of HSPC152 to modulate its activity, either through direct binding or by altering its conformation. HSPC152 is a mitochondrial protein with a dual role in regulating both phosphatase and kinase activities, particularly influencing mitochondrial dynamics and apoptosis. The inhibitors of HSPC152 are often designed to disrupt its function in cellular signaling pathways, particularly those involved in processes such as cell survival, mitochondrial fission, and apoptosis regulation. Structurally, these inhibitors vary widely but usually feature specific chemical scaffolds capable of engaging the active site or relevant domains of the HSPC152 protein, often with high specificity and affinity.
The design of HSPC152 inhibitors requires careful consideration of molecular interactions, particularly because the protein is located within the mitochondria and has a key role in maintaining mitochondrial function and homeostasis. Inhibitors often have to demonstrate mitochondrial permeability to effectively reach their target site. Additionally, they are structured to interact with the protein's key functional motifs without disrupting other cellular processes, as HSPC152 is involved in numerous signaling pathways. The binding of these inhibitors to HSPC152 can lead to alterations in mitochondrial membrane potential and impact processes like cell division and programmed cell death. Understanding the binding mechanisms, chemical modifications to improve specificity, and the bioavailability of HSPC152 inhibitors is crucial for exploring their role in regulating mitochondrial function and protein interactions. The research into the structural features and activity of these inhibitors remains an area of growing interest for biochemical and cellular studies focused on mitochondrial regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D may inhibit TRMT11-2 expression by interfering with RNA polymerase activity, leading to decreased transcription of TRMT11-2 mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide could inhibit TRMT11-2 expression by blocking protein synthesis, thereby preventing the translation of TRMT11-2 mRNA into protein. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Puromycin might inhibit TRMT11-2 expression by prematurely terminating protein synthesis, leading to the degradation of partially translated TRMT11-2 mRNA. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin may inhibit TRMT11-2 expression by blocking protein synthesis, similar to Cycloheximide, thus preventing the translation of TRMT11-2 mRNA. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin might inhibit TRMT11-2 expression by targeting bacterial RNA polymerase, which shares structural similarities with eukaryotic RNA polymerase, leading to decreased transcription of TRMT11-2 mRNA. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-Amanitin may inhibit TRMT11-2 expression by blocking RNA polymerase II activity, which is responsible for transcribing TRMT11-2 mRNA, thus preventing its synthesis. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $352.00 $566.00 $1331.00 $2453.00 | ||
Emetine could inhibit TRMT11-2 expression by blocking protein synthesis, similar to Cycloheximide and Anisomycin, leading to the degradation of partially translated TRMT11-2 mRNA. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin might inhibit TRMT11-2 expression by interfering with protein glycosylation, which is necessary for the proper folding and stability of newly synthesized TRMT11-2 protein. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $360.00 $475.00 | 20 | |
Blasticidin S could inhibit TRMT11-2 expression by causing premature termination of protein synthesis, leading to the degradation of partially translated TRMT11-2 mRNA. | ||||||